Registered Number:06261518 |
For the year ended 30 September 2024
England and Wales
Unaudited Financial Statements
For the year ended 30 September 2024
Drugmart Limited
Contents Page
1
Statement of Financial Position
2 to 5
Notes to the Financial Statements
Drugmart Limited
Statement of Financial Position
2023
2024
425,000
425,000
2
Property, plant and equipment |
135,749
139,319
3
560,749
564,319
98,562
108,497
4
Trade and other receivables |
250,777
253,973
5
108,017
Cash and cash equivalents |
92,393
454,863
457,356
Trade and other payables: amounts falling due within one |
year |
(422,050)
(452,977)
6
35,306
1,886
Net current assets
Total assets less current liabilities |
562,635
599,625
Trade and other payables: amounts falling due after more |
than one year |
(596,275)
(558,087)
7
(2,998)
(845)
Provisions for liabilities |
1,550
Net assets
2,505
100
100
1,450
2,405
1,550
2,505
Shareholders' funds
For the year ended 30 September 2024 the company was entitled to exemption from audit under Section 477 of the Companies Act 2006 relating to small companies. |
The members have not required the company to obtain an audit of its financial statements for the year ended 30 September 2024 in accordance with Section 476 of the Companies Act 2006 |
The directors acknowledge their responsibilities for:a) ensuring that the company keeps proper accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and |
b) preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of |
each financial year and of its profit or loss for each financial year in accordance with the requirements of Section |
394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial |
statements, so far as applicable to the company. |
In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered. |
The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. |
1 of 5
For the year ended 30 September 2024
Drugmart Limited
Statement of Financial Position Continued
Muhammad Irfan Motala Director |
These financial statements were approved and authorised for issue by the Board on 18 February 2025 and were signed by: |
The notes form part of these financial statements |
2 of 5
For the year ended 30 September 2024
Drugmart Limited
Notes to the Financial Statements
Statutory Information
Drugmart Limited is a private limited company, limited by shares, domiciled in England and Wales, registration number |
06261518. |
78 Spotland Road
Rochdale
Lancashire
OL12 6PQ
The presentation currency is £ sterling. |
Basis of preparing the financial statements
These financial statements have been prepared in accordance with the provisions of Section 1A of Financial |
Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the |
Companies Act 2006. The financial statements have been prepared under the historical costs convention as |
modified by the revaluation of certain assets. |
Revenue recognition
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts. |
Property, plant and equipment
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis: |
Computer equipment
Motor vehicles
Fixtures and fittings
No depreciation is provided on the company''s freehold properties since in the opinion of the directors the expected |
useful lives are sufficiently long and the estimated residual values are sufficiently high that any such depreciation |
would be immaterial. The directors undertake an annual impairment review of these properties. |
Inventories
Stocks are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow moving items. Cost includes all direct costs and an appropriate proportion of fixed and variable overheads. |
Hire purchase and leasing commitments
Rentals payable under operating leases are charged against income on a straight line basis over the lease term.
3 of 5
For the year ended 30 September 2024
Drugmart Limited
Notes to the Financial Statements Continued
2. Intangible fixed assets |
Goodwill
425,000
425,000
425,000
425,000
3. Property, plant and equipment |
Motor vehicles
208,171
5,036
83,556
2,450
117,129
3,622
3,622
-
-
-
2,450
83,556
8,658
211,793
117,129
Provision for depreciation and impairment |
68,852
5,036
62,266
1,550
-
Charge for year
7,192
1,195
5,507
490
-
76,044
6,231
67,773
2,040
-
117,129
410
15,783
2,427
135,749
117,129
900
21,290
-
139,319
2023
2024
108,497
98,562
5. Trade and other receivables |
2023
2024
-
237
253,973
250,540
250,777
253,973
4 of 5
For the year ended 30 September 2024
Drugmart Limited
Notes to the Financial Statements Continued
6. Trade and other payables: amounts falling due within one year |
2023
2024
Bank loans and overdraft (secured) |
45,000
43,333
297,029
332,896
Taxation and social security |
13,926
17,221
97,022
28,600
452,977
422,050
7. Trade and other payables: amounts falling due after more than one year |
2023
2024
Bank loans and overdraft (secured) |
350,445
396,275
207,642
200,000
558,087
596,275
8. Average number of persons employed |
During the year the average number of employees was 20 (2023 : 16)
5 of 5